ReleaseWire Connect

An investigation on behalf of investors, who currently hold shares of Catamaran Corp (USA) (NASDAQ:CTRX), was announced concerning whether the takeover of Catamaran Corp by OptumRx is unfair to NASDAQ:CTRX stockholders.

An investigation on behalf of investors, who currently hold shares of Pulse Electronics Corp (OTCMKTS:PULS), was announced concerning whether the takeover of Pulse Electronics Corp by Oaktree Capital Management, L.P at $1.50 is unfair to OTCMKTS:PULS stockholders.

A deadline is coming up on June 18, 2015 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased shares of ECOtality Inc (NASDAQ: ECTY) between April 16, 2013 and August 12, 2013.

A deadline is coming up on May 26, 2015 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased shares of Duoyuan Printing Inc (NYSE: DYP) between November 6, 2009 and March 28, 2011.

An investor in shares of Inland American Real Estate Trust Inc. (OTC: IARE) filed a lawsuit against certain current and former officers and directors of Inland American Real Estate Trust Inc. in connection with management fees.

An investigation on behalf of current long-term investors in shares of Callon Petroleum Company (NYSE:CPE) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Callon Petroleum.

An investor in shares of Hologic, Inc. (NASDAQ:HOLX) filed a lawsuit against Carl C. Icahn and others to recover short swing insider trading profits.

An investigation on behalf of current long-term investors in shares of CTPartners Executive Search Inc (NYSEMKT:CTP concerning potential breaches of fiduciary duties by certain directors and officers of CTPartners Executive Search was announced.

An investigation on behalf of investors of Braskem SA (ADR) (NYSE:BAK) shares over potential securities laws violations by Braskem SA and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors of Adamis Pharmaceuticals Corp (NASDAQ:ADMP) shares over potential securities laws violations by Adamis Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced.